JPS5550943B1 - - Google Patents
Info
- Publication number
- JPS5550943B1 JPS5550943B1 JP6054172A JP6054172A JPS5550943B1 JP S5550943 B1 JPS5550943 B1 JP S5550943B1 JP 6054172 A JP6054172 A JP 6054172A JP 6054172 A JP6054172 A JP 6054172A JP S5550943 B1 JPS5550943 B1 JP S5550943B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2873771 | 1971-06-18 | ||
| FR7219096A FR2141697B1 (cg-RX-API-DMAC7.html) | 1971-06-18 | 1972-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5550943B1 true JPS5550943B1 (cg-RX-API-DMAC7.html) | 1980-12-20 |
Family
ID=26217112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6054172A Pending JPS5550943B1 (cg-RX-API-DMAC7.html) | 1971-06-18 | 1972-06-19 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4169158A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS5550943B1 (cg-RX-API-DMAC7.html) |
| AR (1) | AR192370A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU472247B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE784727A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1003833A (cg-RX-API-DMAC7.html) |
| CH (1) | CH546769A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2229215C2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES403998A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2141697B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1345880A (cg-RX-API-DMAC7.html) |
| NL (1) | NL177893C (cg-RX-API-DMAC7.html) |
| SE (1) | SE392899B (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103002897A (zh) * | 2010-04-23 | 2013-03-27 | 赛特凯恩蒂克公司 | 特定氨基-哒嗪类，与其组合物，及其使用方法 |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2510998B1 (fr) * | 1981-08-07 | 1986-01-10 | Sanofi Sa | Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent |
| FR2510997A1 (fr) * | 1981-08-10 | 1983-02-11 | Sanofi Sa | Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant |
| FR2511366A1 (fr) * | 1981-08-11 | 1983-02-18 | Sanofi Sa | Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
| FR2539741A1 (fr) * | 1983-01-21 | 1984-07-27 | Sanofi Sa | Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent |
| FR2539742B1 (fr) * | 1983-01-24 | 1986-09-05 | Sanofi Sa | Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central |
| FR2539739B1 (fr) * | 1983-01-24 | 1985-11-22 | Sanofi Sa | Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant |
| FR2540115B1 (fr) * | 1983-01-28 | 1985-06-07 | Sanofi Sa | Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant |
| CA1218655A (en) * | 1983-01-28 | 1987-03-03 | Kathleen Biziere | Process for the preparation of pyridazine derivatives having a psychotropic action |
| FR2555178B1 (fr) * | 1983-11-18 | 1986-04-18 | Sanofi Sa | Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant |
| FR2625201B1 (fr) * | 1987-12-24 | 1990-06-15 | Sanofi Sa | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant |
| US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
| PT93060B (pt) | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
| FR2642648B1 (fr) * | 1989-02-07 | 1991-06-21 | Sanofi Sa | Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique |
| FR2642757B1 (fr) * | 1989-02-07 | 1991-05-24 | Sanofi Sa | Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant |
| FR2642754B1 (fr) * | 1989-02-07 | 1991-05-24 | Sanofi Sa | Nouveaux derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant |
| US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
| EP2264014A1 (en) | 2001-08-31 | 2010-12-22 | Université Louis Pasteur | Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors |
| CN101087766B (zh) | 2004-11-02 | 2011-09-07 | 西北大学 | 哒嗪化合物、组合物和方法 |
| ATE523199T1 (de) | 2004-11-02 | 2011-09-15 | Univ Northwestern | Pyridazinverbindungen und verfahren |
| CA2614116A1 (en) * | 2005-07-04 | 2007-01-11 | Novo Nordisk A/S | Novel medicaments |
| RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
| US20090325973A1 (en) * | 2006-04-28 | 2009-12-31 | Watterson D Martin | Formulations containing pyridazine compounds |
| EP2015750A2 (en) | 2006-04-28 | 2009-01-21 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
| WO2007127448A2 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Salts of pyridazine compounds |
| CA2653062A1 (en) | 2006-05-23 | 2007-11-29 | Transtech Pharma, Inc. | 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament |
| PT2079732E (pt) | 2006-05-29 | 2012-02-02 | High Point Pharmaceuticals Llc | 3-(1,3-benzodioxol-5-il)-6-(4-ciclopropilpiperazin-1-il)- piridazina, os seus sais e solvatos e a sua utilização a título de antagonista do receptor h3 de histamina |
| EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
| US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
| AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
| US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| EP3743721B1 (en) | 2018-01-23 | 2021-11-17 | Institut Gustave Roussy | Minaprine for use in reducing tumor growth |
-
1971
- 1971-06-18 GB GB2873771A patent/GB1345880A/en not_active Expired
-
1972
- 1972-05-29 FR FR7219096A patent/FR2141697B1/fr not_active Expired
- 1972-06-12 BE BE784727A patent/BE784727A/xx not_active IP Right Cessation
- 1972-06-12 CA CA144,468A patent/CA1003833A/en not_active Expired
- 1972-06-15 DE DE2229215A patent/DE2229215C2/de not_active Expired
- 1972-06-16 SE SE7207999A patent/SE392899B/xx unknown
- 1972-06-16 AU AU43500/72A patent/AU472247B2/en not_active Expired
- 1972-06-16 CH CH903672A patent/CH546769A/fr not_active IP Right Cessation
- 1972-06-17 ES ES403998A patent/ES403998A1/es not_active Expired
- 1972-06-19 AR AR242634A patent/AR192370A1/es active
- 1972-06-19 NL NLAANVRAGE7208355,A patent/NL177893C/xx not_active IP Right Cessation
- 1972-06-19 JP JP6054172A patent/JPS5550943B1/ja active Pending
-
1977
- 1977-07-29 US US05/820,489 patent/US4169158A/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103002897A (zh) * | 2010-04-23 | 2013-03-27 | 赛特凯恩蒂克公司 | 特定氨基-哒嗪类，与其组合物，及其使用方法 |
| JP2013525376A (ja) * | 2010-04-23 | 2013-06-20 | サイトキネティクス・インコーポレーテッド | 特定のアミノピリダジン、その組成物、及びこれらの使用方法 |
| CN103002897B (zh) * | 2010-04-23 | 2017-06-09 | 赛特凯恩蒂克公司 | 特定氨基‑哒嗪类，与其组合物，及其使用方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1003833A (en) | 1977-01-18 |
| BE784727A (fr) | 1972-10-02 |
| AU472247B2 (en) | 1973-12-20 |
| CH546769A (fr) | 1974-03-15 |
| NL7208355A (cg-RX-API-DMAC7.html) | 1972-12-20 |
| AU4350072A (en) | 1973-12-20 |
| GB1345880A (en) | 1974-02-06 |
| DE2229215A1 (de) | 1973-01-25 |
| AR192370A1 (es) | 1973-02-14 |
| FR2141697B1 (cg-RX-API-DMAC7.html) | 1976-09-17 |
| US4169158A (en) | 1979-09-25 |
| SE392899B (sv) | 1977-04-25 |
| ES403998A1 (es) | 1975-06-01 |
| NL177893B (nl) | 1985-07-16 |
| DE2229215C2 (de) | 1984-09-06 |
| NL177893C (nl) | 1985-12-16 |
| FR2141697A1 (cg-RX-API-DMAC7.html) | 1973-01-26 |